Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/ERADIA

Authorized

STANDARD

ERADIA

VIRBAC AH, INC.🇨🇦 Health Canada

Approval Date: Feb 5, 2026
Approval ID: 642c3c78b27b6b08
Company: VIRBAC AH, INC.
Type: Standard

Approval Details

Approval Id: 642c3c78b27b6b08
Drug Approval Canada Name: ERADIA
Product Name: ERADIA
Status: Marketed
Status Date: 2021-01-12
Original Market Date: 2021-01-12
Drug Class: Veterinary
Dosage Form: Suspension
Route Of Administration: Oral
Schedule: Prescription
Atc Original: Not Applicable
Aig Number: 0102572011
Company Name: VIRBAC AH, INC.
Company Address: Po Box/Cp 162059 Fort Worth Texas United States 76161

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 5, 2026

Approval ID

642c3c78b27b6b08

Type

Standard

Back to Health Canada Approvals

ERADIA - Health Canada Drug Approval Details